Corporate Team

Our corporate team consists of highly skilled scientists and researchers who have lead the international effort to harness the knowledge arising from the use of stem cells for the treatment of Idiopathic Pulmonary Fibrosis (IPF), led by Professor Demosthenes Bouros. International recognition, past experience and on-going collaborations with scientific centers of excellence both national and overseas is our roadmap to success. The technical and scientific capacity of our team is of highest possible standard.

Bouros Demosthenes

Professor of Pneumonology

+30 25510 76106 bouros@med.duth.gr

Head of the Pneumonology Department, DUTH University Hospital of Evros. Member of the international commission of experts of the American Thoracic Society and the European Respiratory Society (ATS/ERS) for the new classification of Idiopathic Interstitial Pneumonias, and of the international guidelines for the diagnosis and treatment of IPF. Researcher at Harvard University and Visiting Professor at Boston University, Research Associate at the National Heart and Lung Institute at Imperial College London and Visiting Professor at the Medical University of Vienna. He leads the scientific team and performed the world's first successful stem cell transplantation in patients with Idiopathic Pulmonary Fibrosis. Has more than 340 international scientific publications (> 6.000 citations).

Kolios George

Professor of Pharmacology

+30 25510 30368 gkolios@med.duth.gr

Head of the Laboratory of Pharmacology, Faculty of Medicine, DUTH and Head of the Laboratory of Clinical Pharmacology, University Hospital of Evros. Director of the Master’s degree Program “Clinical Pharmacology and Therapeutics”, DUTH. Member of the Scientific Board for Drug Approval, Greek National Organization for Medicines. Visiting Professor of Pharmacology, Department of Pharmacology, University of Bath, UK. Visiting Researcher at the Laboratory of Molecular Immunology, National Institute of Health (NIH) and at the Institute of Immunology, School of Medicine, Mount Sinai (USA). He has conducted significant laboratory and clinical research with emphasis on immunopharmacology and the study of the pathogenetic mechanisms that govern inflammation and fibrosis

Pneumatikos Ioannis

Professor of Intensive Care

+30 25510 75081 ipnevmat@med.duth.gr

Pulmonologist/Intensivist (MD, PhD, FCCP), received his training in Intensive Care at the University of Amsterdam. Director in the Critical Care Department in the University Hospital of Alexandroupolis. He is a member of the American College of Chest Physicians. His research is focused on the pathogenesis of acute respiratory distress syndrome (ARDS), the pathogenesis of ventilator associated pneumonia and the interaction between sepsis and coagulation. In the last years his research has focused in the investigation of the complexity of critical illness using mathematical models.

Tzouvelekis Argyris

Post-doctoral Researcher

Pneumonologist. Leading investigator in the world’s first prospective, nonrandomized clinical trial (Phase IB) associated with the successful transplantation of autologous stem cells in patients with Idiopathic Pulmonary Fibrosis (Tzouvelekis et al. Translational Medicine 2013). Currently a postdoctoral Researcher at the University of Yale, School of Medicine, Department of Internal Medicine, Division of Pulmonary, Critical Care and Sleep Medicine (New Heaven, CT, USA).

Konstantinidis Nikolaos

Researcher

niko.bioinformatics@gmail.com

Bioinformatician (MSc Neural Networks). Received his training at the University of Frankfurt (Germany). Worked in Max-Planck Institute (Germany) in the development of training algorithms (artificial intelligence) for modeling disease parameters. Researcher in the project “Functional Genomics in the pathogenesis of Idiopathic Pulmonary Fibrosis” (NSRF), Dept. Pneumonology, DUTH.